AI English summary of an SEC filing — figures as filed

West Pharmaceutical Services said Eric M. Green, President, Chief Executive Officer and Chair of the Board, informed the Board on March 6, 2026 of his intent to retire once his successor has been hired. The company said it made the announcement on March 9, 2026.

8-KDeparture or Appointment of Directors or Certain OfficersFiled Mar 9, 2026Period of report Mar 9, 2026Summary published (UTC) Oct 2, 2026

Key points

AI summary

West Pharmaceutical Services said Eric M. Green, President, Chief Executive Officer and Chair of the Board, informed the Board on March 6, 2026 of his intent to retire once his successor has been hired. The company said it made the announcement on March 9, 2026.
The company said the Board is engaging a leading executive recruiting firm to search for a successor and expects the transition to occur in the second half of 2026.
The company said it is reaffirming the financial guidance it provided in its February 12, 2026 earnings release for 2026 alongside this announcement.
West said Green served as President and Chief Executive Officer from April 2015 and as Chair of the Board from May 2022, and that during his 11-year tenure, sales more than doubled and total shareholder return was approximately 350%.

Summary

AI-written

Analysis scope · Filing body and confirmed press-release exhibitWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.

Eric M. Green to Retire as CEO and Chair

West Pharmaceutical Services said Eric M. Green, President, Chief Executive Officer and Chair of the Board, informed the Board on March 6, 2026 of his intent to retire once his successor has been hired. The company said it made the announcement on March 9, 2026.

Source · Based on the filing body and exhibits

Successor Search and Transition Timing

The company said the Board is engaging a leading executive recruiting firm to search for a successor and expects the transition to occur in the second half of 2026.

Source · Based on the filing body and exhibits

Reaffirms 2026 Financial Guidance

The company said it is reaffirming the financial guidance it provided in its February 12, 2026 earnings release for 2026 alongside this announcement.

Source · Based on the filing body and exhibits

Green's Tenure and Achievements Cited by West

West said Green served as President and Chief Executive Officer from April 2015 and as Chair of the Board from May 2022, and that during his 11-year tenure, sales more than doubled and total shareholder return was approximately 350%.

Source · Based on the filing body and exhibits

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.

View the original filing on SEC EDGAR ↗

Unauthorized scraping, data storage and database creation prohibited

Without prior written consent, you must not crawl or scrape data compiled and organized by Chickstock or its analysis and summaries, or collect them repeatedly or in bulk for storage, ingestion or database creation. Repurposing, redistribution, sale and use to build other services are also prohibited.

Unauthorized use may result in access restrictions, demands to stop infringement and delete copies, and claims for damages. Violations of applicable law may also give rise to criminal liability.

Uses permitted by law, the Terms of Service or a separate agreement remain subject to their respective scope. Rights in individual source materials, including original filings, remain with their respective rights holders.